May 30, 2023

Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute

Tuesday, May 30th, 2023 PRESS RELEASE Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute Winnipeg, MB – May 30th, 2023 – Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute. The Cubresa BrainPET is a…

Read More >

April 5, 2023

Manitoba Inc. Magazine features Cubresa

Cubresa is pleased to have been featured in an article in the Manitoba Inc Magazine. For the electronic version, see the link below. Manitoba’s Cubresa provides a world-leading window on the mind The BrainPET is an investigational device and NOT AVAILABLE FOR COMMERCIAL SALE. Clinical use pending FDA 510(k) and Health Canada approvals.

Read More >

January 23, 2023

The Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital selects Cubresa’s BrainPET Insert System to support brain research studies

PRESS RELEASE The Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital selects Cubresa’s BrainPET Insert System to support brain research studies Winnipeg, MB – Jan 23rd, 2023 – The Martinos Center has selected Cubresa’s investigational BrainPET System to add to their suite of imaging tools. The Cubresa BrainPET Insert System will benefit…

Read More >

November 29, 2022

Cubresa Announces the Appointment of 2 New Board Members

Tuesday, November 29th, 2022 PRESS RELEASE Cubresa Appoints Mr. Ryan Klassen and Ms. Trudy Martens to Board of Directors  Winnipeg, MB – November 29th, 2022 – Cubresa Inc., a world leader in brain imaging, is announcing two 2 appointments to its board of directors, Mr. Ryan Klassen, and Ms. Trudy Martens. “The directors and I are…

Read More >

July 7, 2022

Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mariluz Alejo as Director of Quality

Thursday, July 7th, 2022PRESS RELEASE Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality Winnipeg, MB – July 7th, 2022 – Cubresa Inc., a world leader in the design and development of PET insert systems for brain imaging, is announcing two new senior appointments: Mr. Matt Hudson…

Read More >

June 20, 2022

DOTMed HealthCare magazine features Cubresa

Cubresa is pleased to have its clinical BrainPET insert system and preclinical NuPET Bio scanner, designed for use in infectious disease research, featured on page 44 in the June 2022 issue of DOTMed’s HealthCare Business News magazine. DOTMed HealthCare link The BrainPET is an investigational device and NOT AVAILABLE FOR COMMERCIAL SALE.

Read More >

May 2, 2022

Lawson Health Research Institute selects Cubresa’s BrainPET system to support neurological research studies

Monday, May 2nd, 2022 PRESS RELEASE Lawson Health Research Institute selects Cubresa’s BrainPET system to support neurological research studies Winnipeg, MB – May 2nd, 2022 – Lawson Health Research Institute has selected Cubresa’s investigational BrainPET system to add to their suite of imaging tools. The BrainPET scanner will be used to support neurological research studies…

Read More >

April 29, 2022

Brain & Brain PET 2022

Cubresa Inc. will take part in Brain & Brain PET in Glasgow, Scotland from May 29th to June 1st. Please join us at the technical exhibition. See you at @Brain2022!

Read More >

April 29, 2022

ISMRM 2022

Cubresa Inc. is pleased to participate in ISMRM 2022 from May 8th to 12th in London, England. Please join us at the technical exhibition at booth D22. We look forward to seeing you in London! 

Read More >